After the online training, the number of patients who refused to take prescribed VTE prophylaxis dropped from 12.4 to 11.1%, the investigators found.

According to a new study published in the Canadian Journal of Cardiology, a significant number of high-risk patients are not receiving recommended venous thromboembolism (VTE) prophylaxis ...

Many successful interventions have improved venous thromboembolism (VTE) prophylaxis for hospitalized patients. Yet, a significant proportion of doses of prescribed preventive medications are not ...

Nurse leaders in the nurse feedback arm received monthly scorecards detailing VTE prophylaxis administration practices by individual nurse. Credit: Journal of the American Heart Association (2022 ...

Venous thromboembolisms (VTE), or blood clots in the veins, affect as many as 900,000 Americans in the U.S. each year, about 50 percent of them are healthcare-associated, and as many as 70 percent ...

Findlay J, Keogh M, Cooper L. “Venous thromboembolism prophylaxis: the role of the nurse. British Journal of Nursing. 2010; 19(16):1028-1032. Rice KL, Walsh ME.

Importantly, there was no significant difference in the rates of venous thromboembolism for patients receiving and not receiving pharmacologic prophylaxis (0.72% vs 0.86%; P = .26).

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

However, even with prophylaxis, approximately 1 in 100 patients undergoing knee replacement and 1 in 200 patients undergoing hip replacement will develop a DVT before hospital discharge. [ 3 ] ...

To reduce the likelihood of patients developing VTE, nurses need to take an individualised approach to patient education to increase adherence to treatment. ... MacLellen DG, Fletcher JP (2007) ...

(HealthDay)—Almost all emergency general surgery (EGS) patients treated operatively and nonoperatively have increased risk of venous thromboembolism (VTE) and should receive prophylactic ...

Venous thromboembolisms (VTE), or blood clots in the veins, affect as many as 900,000 Americans in the U.S. each year, about 50 percent of them are healthcare-associated, and as many as 70 percent ...